drugset / Trial / NCT04384991
HU007 Eye Drops in Patients With Dry Eye Syndrome
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is a multicenter, randomized, double blind, Restasis-controlled non-inferiority, Phase III Study to evaluate the efficacy and safety of HU007 eye drops in patients With dry eye syndrome
Timeline
- Start
- 2019-05-03
- Primary completion
- 2019-12-05
- Completion
- 2019-12-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 0.02 % | Other |
| Subject | Cyclosporine | Peptide | 0.05 % | Other |